期刊
NATURE COMMUNICATIONS
卷 10, 期 -, 页码 -出版社
NATURE PORTFOLIO
DOI: 10.1038/s41467-019-12771-9
关键词
-
资金
- National Basic Research Plan of China [2018YFA0208903]
- National Natural Science Foundation of China [81972894, 81673364]
- Ministry of Science and Technology of the People's Republic of China [2017ZX09101001006]
- Fundamental Research Funds for the Central Universities [2632018ZD13]
- Six Talents Summit Program of Jiangsu Province
- Priority Academic Program Development of Jiangsu Higher Education Institutions
One of the main challenges for immune checkpoint blockade antibodies lies in malignancies with limited T-cell responses or immunologically cold tumors. Inspired by the capability of fever-like heat in inducing an immune-favorable tumor microenvironment, mild photothermal therapy (PTT) is proposed to sensitize tumors to immune checkpoint inhibition and turn cold tumors hot. Here we present a combined all-in-one and all-in-control strategy to realize a local symbiotic mild photothermal-assisted immunotherapy (SMPAI). We load both a near-infrared (NIR) photothermal agent IR820 and a programmed death-ligand 1 antibody (aPD-L1) into a lipid gel depot with a favorable property of thermally reversible gel-to-sol phase transition. Manually controlled NIR irradiation regulates the release of aPD-L1 and, more importantly, increases the recruitment of tumor-infiltrating lymphocytes and boosts T-cell activity against tumors. In vivo antitumor studies on 4T1 and B16F10 models demonstrate that SMPAI is an effective and promising strategy for treating cold tumors.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据